The detection and measurement of oncodevelopmental proteins in gynecological malignant disease.
Data from the literature and our own measurements with alpha-fetoprotein (AFP), carcinoembryonal antigen (CEA), alpha 2-pregnancy-associated globulin (alpha 2-PAG), human chorionic gonadotropin (HCG), human placental lactogen (HPL) and pregnancy-specific beta 1-glycoprotein (SP-1) are related to clinical data. Only AFP in endodermal tumors and HCG in germ cell carcinomas can be used for clinical monitoring.
D002272:Carcinoembryonic Antigen / Q000032:analysis; D006063:Chorionic Gonadotropin / Q000097:blood; D004407:Dysgerminoma / Q000097:blood; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood*; D006801:Humans; D008649:Mesonephroma / Q000097:blood; D009363:Neoplasm Proteins / Q000097:blood*; D010928:Placental Lactogen / Q000097:blood; D011257:Pregnancy Proteins / Q000032:analysis; D011268:Pregnancy-Specific beta 1-Glycoproteins / Q000032:analysis; D000509:alpha-Fetoproteins / Q000032:analysis
D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D009363:Neoplasm Proteins; D011257:Pregnancy Proteins; D011268:Pregnancy-Specific beta 1-Glycoproteins; D000509:alpha-Fetoproteins; D010928:Placental Lactogen